National Lung Cancer Partnership/The LUNGevity Foundation 2008 Research Grant Program Request for Applications Purpose of Grant The purpose of this Grant Program is to drive research forward that will increase understanding of lung cancer risk, biology, and response to treatment. National Lung Cancer Partnership and the LUNGevity Foundation are particularly interested in research that will aid in prevention, detection, diagnosis, screening, treatment, and symptom management of lung cancer. Two grants are available: • One Grant is available specifically for research in the area of sex differences in lung cancer. • One Grant is available for research pertaining to any facet of lung cancer. The Research Grant is intended as seed money for promising novel research for a faculty member at any level to carry out research in lung cancer. The Research Grant will be awarded for one or two years, for up to $50,000 per year ($100,000 maximum over 2 years). The Grant is designed to be used primarily for research support, including technical assistance, supplies, reagents, and equipment. It is the policy of National Lung Cancer Partnership and the LUNGevity Foundation not to provide indirect costs to the Grant recipient’s institution. Eligibility 1. At the time of application, an applicant must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent), have completed all post-doctoral training, and have a faculty appointment at any not-for-profit institution anywhere in the world. Pre- and post-doctoral fellows and research associates are not eligible for the Research Grant. 2. Applications will only be accepted for Research Plans involving lung cancer research. Applications addressing sex differences in lung cancer are especially encouraged. 3. The Research Plan may be carried out at any accredited non-profit research institution throughout the world. If the applicant is performing research outside of their home country, verification of work visa must be provided. 4. The Research Grant recipient may hold any other fellowship, award, or grant during the time of the award. 5. The Research Grant recipient may not have knowingly received any research funding from the tobacco industry, its parent companies or subsidiaries, within the last 5 years. 6. Applications involving animals must receive approval from the institution’s Animal Care and Use Committee before award commencement. 7. Applications involving human participants must receive approval from the local Institutional Review Board before award commencement. 8. National Lung Cancer Partnership and the LUNGevity Foundation will not discriminate on the basis of gender, race, creed, religion, sexual orientation, disability, nationality, age or any other factor irrelevant to the quality of the application. Award Information The deadline for grant applications is September 2, 2008. Applications must be electronically submitted and postmarked on or before this deadline. Awards will be announced on or before December 15, 2008. The Research Grant is subject to annual review, and may be granted for a maximum of $50,000 per year for two years. The second year of support is based on the applicant’s demonstration of satisfactory progress.
Contact Us National Lung Cancer Partnership 222 N. Midvale Blvd., Suite 6 Madison, WI 53705 Phone: 608.233.7905 Fax: 608.233.7893 E-mail: info@NationalLungCancerPartnership.org www.NationalLungCancerPartnership.org
2009 AASLD CAREER DEVELOPMENT AWARD IN LIVER TRANSPLANTATION IN MEMORY OF THE UNIVERSITY OF MICHIGAN TRANSPLANT TEAM Application Deadline: September 2, 2008 DESCRIPTION The purpose of this award is to foster career development for an individual performing clinical and/or translational research in the field of liver transplantation and who has shown commitment to excellence in the field at an early stage of his or her career. OBJECTIVE The award is designed to support a junior faculty member in the development of liver transplant research so that further funding can be obtained. ELIGIBILITY In order to be eligible for this award, the applicant must meet the following criteria: 1. Applicant must be in the first five years of appointment as a junior faculty member (instructor or assistant professor) at a UNOS approved transplant center who spends 50% or more of his/her time in clinical transplantation or transplantation-related sciences. 2. Applicant must show commitment to making substantial contributions to the field of liver transplantation. 3. Applicant does not hold other similar research awards. Applicants who hold other research awards (NIH-K08, NIH-K23, Veterans Administration-Research Associate, Clinical Investigator, AGA Research Scholar Award, Glaxo Institute of Digestive Health Award, American Liver Foundation Liver Scholar Award, etc.) are not eligible. 4. Sponsor should be the applicant's research mentor and must be an AASLD member in good standing. 5. Applicant must be an AASLD member in good standing by the award start date. AWARD AND REQUIREMENTS One award of $90,000 will be provided over two years ($45,000 per year). Money may be used for salary support or for technical support/laboratory supplies for the investigator and no indirect costs are provided. It is expected that additional funds are available to the candidate in order to carry out the proposed research. This award is intended to support the recipient’s continued research. Funds will be issued to the recipient’s institution and are not transferable from one recipient to another. The award cannot be transferred to another institution without prior written approval from AASLD. Recipients must acknowledge the award in all publications resulting from research performed during the tenure of this award. Abstracts, manuscripts, or other articles that reflect research funded by this award must acknowledge support from AASLD, and copies must be forwarded to AASLD. In addition, a scientific progress and financial report must be sent to AASLD at the end of each award year and at the time when the award is complete. Funding of the second year of the award is contingent upon receipt of a first year progress report. All awardees are strongly encouraged to present their work at The Liver Meeting®. SELECTION CRITERIA Candidates will be evaluated based upon their background, their commitment to a research career, the strength of their research project and the environment in which they will conduct this project. REVIEW PROCESS The AASLD Awards Committee will review the nominations received by the submission deadline and will make final recommendations to the AASLD Governing Board. DEADLINE Send the original and 14 three-hole punched copies of the completed application (including support materials) in one package by 5 pm Eastern on September 2, 2008 to AASLD, 1001 N. Fairfax St., Suite 400, Alexandria, VA 22314 Attention: Career Development Award Note: Do not staple any part of the application package. NOTIFICATION DATE/START DATE Notification date will be October 2008 for a July 2009 start date. Recipients will be recognized during The Liver Meeting® 2008, October 31 - November 4 in San Francisco, California. Support of this award by Astellas USA Foundation is gratefully acknowledged.
Questions? Contact Denise Davis or Kristin Hutcherson via email at awards@aasld.org or call 703-299-9766.
The Macular Degeneration Research Program (MDR) is a new program of AHAF. Since 1999, AHAF has awarded over $7.7 million to support basic research into the causes and potential treatments of this disease. MDR is currently supporting 25 biomedical researchers.
Standard Award (maximum of $50,000 per year for up to two years, renewable on a competitive basis) For the 2009 competition, the Letters of Intent are due at AHAF by July 10, 2008. The Grant Application Information page has specific Letter of Intent instructions. If you are invited to submit an application, it must be received by October 20, 2008.
Macular Degeneration Research MDR employs a two tiered review process in which proposals are first submitted by Letter of Intent. The Letters are individually ranked by 3-5 reviewers. These preliminary grades are not accompanied by formal written critiques of the proposal, and are used solely as a triage process to identify only the most competitive proposals. In consultation with the Chair of the MDR Scientific Review Committee the AHAF Research Grants Staff invites the most enthusiastically reviewed Letters of Intent to submit a full application, which are reviewed as noted above. The cut-off line is based on number of received proposals and fluctuates each year.
American Health Assistance Foundation 22512 Gateway Center Drive Clarksburg, Maryland 20871 Phone: 1-800-437-2423 or (301) 948-3244 Fax: (301) 258-9454
Research Grants Guy Eakin, Ph.D., Director of Research Grants: geakin@ahaf.org
Conference on Innovations in Trauma Research MethodsNovember 16-17, 2008 Hotel Orrington Chicago's North Shore CITRM 2008 TRAVEL STIPENDS FOR UNDER-REPRESENTED RESEARCHERS DEADLINE: JULY 15, 2008 Thank you for your interest in CITRM travel stipends. Travel stipends are provided on a competitive basis to members of under-represented groups, with application materials submitted to the CITRM Travel Stipend Selection Committee. "Under-represented" is here defined as members of a North American racial or ethnic minority group (including African American, Hispanic American, Asian American, Native American, or Pacific Islander); a member of a legally-defined physically challenged group; or a citizen or permanent resident of those nations with economies defined by the World Bank as low income, lower middle income, or upper middle income, on the basis of gross national income (for a complete list of World Bank-categorized nations, see website link: http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0,,contentMDK:20421402~menuPK:64133156~pagePK:64133150~piPK:64133175~theSitePK:239419,00.html#lincome.). Stipends are available for both novice researchers and more experienced scientists. "Novice Researchers" are defined as those who completed training less than 5 years prior to application time. In turn, "Experienced Researchers" are defined as individuals who completed training 5 or more years prior to application. Stipends will include conference fee waiver and funding toward airfare and lodging at the CITRM conference hotel.
For more information, contact Lauren McSweeney at: Lauren.McSweeney@va.gov.
The Parker B. Francis Fellowship in Pulmonary Research is intended to support the development of outstanding investigators who plan careers in pulmonary research. We seek to help them as they make the transition to independent, self-supporting, faculty members. Parker B. Francis Fellowship grants are awarded to institutions for the purpose of providing stipends, fringe benefits, and modest travel expenses in support of qualified post-doctoral fellows or newly appointed assistant professors. Award recipients will thereby be enabled to devote the major part of their professional effort to research related to pulmonary disease and lung biology. Grants are made for three years of support. It is permissible to maintain support for the awardee as he or she moves from fellowship to faculty status. Awards are made to institutions on behalf of the fellows and can be transferred to other institutions only under special circumstances with prior approval from the Director of the Fellowship Program. Fellows supported by a Parker B. Francis Fellowship must be assured of having at least 75 percent of their time available for research. This means that a total of no more than three months per year may be spent in clinical or other non-research activities.
GENERAL INFORMATION APPLICANTS The ideal candidate is one with evidence of strong aptitude in research and who is in transition from post-doctoral trainee to independent investigator. It is essential that there be evidence of accomplishment and proficiency in research. Few applicants who are just beginning research training and have only one or two research publications are funded. Candidates with greater than seven years since the doctoral degree should include reasons for continued training. Candidates may hold any relevant doctoral degree (e.g., M.D., Ph.D., Sc.D., D.V.M., Dr. P.H.). Fellowships are restricted to US, Canadian and Mexican citizens or permanent residents. However, foreign nationals who document their initial steps toward permanent residence in the US, Canada or Mexico will also be considered. Documentation should include a description of steps already taken toward application for long-term residency or citizenship. MENTORS Mentorship of the fellow by an established investigator is required. Any established faculty scientist at a university or a not-for-profit research institution may mentor a candidate for fellowship. Mentors at government or corporate laboratories are not eligible. The mentor should be in a position to guarantee that 75 percent of a fellow's time is available for research. The mentor should be committed to fostering the candidate's career advancement and should be the primary scientific advisor. Secondary scientific mentors at the same or a different institution are encouraged but not required. Their roles should be described in the body of the application. Many fellows spend some portion of their fellowship years working with a secondary mentor at another institution. INSTITUTIONS There are no restrictions regarding discipline or department. Clinical or basic science departments are suitable; however, it is expected that the proposed research will focus on lung biology or lung disease. Awards are limited to institutions located in the US, Canada and Mexico. Each department may submit only one application annually and is limited to a maximum of two active fellowships at any one time. NOTES ABOUT OTHER GRANT SUPPORT Having an NIH K series or similar award at the time of application makes one ineligible for a PBF Fellowship. However, once awarded, a PBF Fellow may accept such a grant, as long as the basic requirements of the PBF Fellowship are met (75 percent of time available for research and PBF funds used only for salary and travel). Most importantly, the area of lung research pursued should remain the same. Previous individual or institutional NIH or MRC training grants do not make one ineligible, although they must be relinquished if a PBF Fellowship is awarded. Individuals are ineligible for a PBF Fellowship if they are the principal investigator on an NIH RO1 or similar research grant when applying for a PBF Fellowship. But Fellows in their second or third year may have their own NIH RO1 or similar grant. In fact, obtaining research grants is an appropriate goal for PBF Fellows. Since fellowship funds are restricted to the Fellow's salary and travel, in some cases it may not be possible to utilize the full level of PBF Fellowship support. Awards will not be given if either the fellow or mentor currently holds funding from the tobacco industry, even if the tobacco monies will not be used to support the PBF sponsored research. APPROPRIATE TOPICS A broad array of approaches to lung biology and respiratory medicine, ranging from cell and molecular studies, to those involving epidemiologic and clinical aspects of human subjects are appropriate. We also encourage applications from pulmonary medicine specialists interested in pursuing research in bioethical aspects of pulmonary medicine or critical care. Potential topics include, but are not limited to, the ethics of clinical trials in critical care, end-of-life decisions and resource allocation. The context of all these topics should be pulmonary biology and lung disease. Applicants must meet all the eligibility standards. Mentors and/or applicants considering whether a particular area is appropriate are encouraged to discuss potential projects with the Director of the PBF Fellowship Program in Seattle, Washington (trmartin@u.washington.edu).
MAILING ADDRESS Thomas R. Martin, M.D. Director Parker B. Francis Fellowship Program Pulmonary Research Laboratories VA Puget Sound Health Care System 1660 S. Columbian Way, 151L Seattle, WA 98108 DEADLINE Applications must be received no later than Friday, October 17, 2008.
1234567891011...26next
